Home › Myelodysplastic Syndromes › Arizona › Tucson
Myelodysplastic Syndromes clinical trials in Tucson, AZ
3 studies for Myelodysplastic Syndromes are looking for participants at sites in and around Tucson (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
RecruitingPhase 2
- Banner University Medical Center - Tucson, Tucson
- University of Arizona Cancer Center-North Campus, Tucson
Prophylactic DLI-X for Leukemia Relapse After HCT
RecruitingPhase 1
- The University of Arizona Cancer Center, Tucson
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
RecruitingPhase 1/2
- Banner University Medical Center - Tucson, Tucson
About Myelodysplastic Syndromes
Myelodysplastic Syndromes (MDS) are rare. They are sometimes found during a routine blood test. Learn symptoms, risk factors, and treatment options.
More about Myelodysplastic Syndromes on MedlinePlus
Myelodysplastic Syndromes trials in other cities
- Houston, TX43 studies
- Baldwin Park, CA27 studies
- New York City, NY22 studies
- Seattle, WA21 studies
- Boston, MA20 studies
- Tampa, FL20 studies
- Washington, DC19 studies
- Miami, FL17 studies
- Durham, NC14 studies
- Columbus, OH14 studies
- Atlanta, GA13 studies
- Chicago, IL13 studies
Other studies in Tucson
- Obesity20 studies
- Breast Cancer18 studies
- Non-Small Cell Lung Cancer18 studies
- Overweight17 studies
- Metastatic Cancer14 studies
- Type 2 Diabetes13 studies
- Cancer (all types)12 studies
- Prostate Cancer12 studies
- Colorectal Cancer11 studies
- Cardiovascular Disease11 studies
- Steatotic Liver Disease10 studies
- Acute Myeloid Leukemia10 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.